“Abbott said a trial of 1,200 patients with moderate-to-severe psoriasis showed that 71 percent who were treated with Humira showed at least 75 percent skin clearance after 16 weeks, compared with 6.5 percent of patients given a placebo.”
Abbott also says it will seek FDA approval of Humira for psoriasis in the first half of this year. Humira is already approved for psoriatic arthritis.
Category: Uncategorized
